Tuberculin Skin Test Interpretation for Tuberculosis Detection
A positive tuberculin skin test indicating tuberculosis infection is determined by measuring the induration size, with specific cutoff thresholds based on patient risk factors: ≥5 mm for high-risk individuals, ≥10 mm for moderate-risk individuals, and ≥15 mm for low-risk individuals. 1
Interpretation Criteria by Risk Group
Induration ≥5 mm is considered positive in:
- HIV-positive individuals 1
- Recent contacts of TB cases 1
- Persons with fibrotic changes on chest radiographs consistent with prior TB 1
- Organ transplant recipients and other immunosuppressed patients (receiving ≥15 mg/day of prednisone for >1 month) 1
- Residents and employees of high-risk congregate settings (prisons, nursing homes, hospitals, homeless shelters) 1
- Mycobacteriology laboratory personnel 1
- Children younger than 4 years of age or those exposed to adults in high-risk categories 1
Induration ≥10 mm is considered positive in:
- Recent arrivals (<5 years) from high-prevalence countries 1
- Injection drug users 1
- Persons with clinical conditions that increase TB risk (silicosis, diabetes mellitus, chronic renal failure, certain hematologic disorders, specific malignancies, weight loss >10% of ideal body weight, gastrectomy, jejunoileal bypass) 1
- Residents and employees of high-risk congregate settings not in the highest risk category 1
Induration ≥15 mm is considered positive in:
- Persons with no known risk factors for TB 1
- Individuals at low risk for whom testing is not generally indicated 1
Special Considerations
BCG Vaccination History
- No reliable method exists to distinguish tuberculin reactions caused by BCG vaccination from those caused by natural TB infection 1
- A positive test in BCG-vaccinated persons should be considered indicative of TB infection, especially in persons from high-prevalence countries 1
- Reasons to not attribute positive results to BCG vaccination:
Skin Test Conversion
- For persons with negative tuberculin skin test reactions who undergo repeat testing, an increase in reaction size of ≥10 mm within 2 years should be considered a skin test conversion indicative of recent infection 1
- For individuals previously infected with nontuberculous mycobacteria or BCG-vaccinated, conversion is defined as an increase in induration by 10 mm on subsequent tests 1
Anergy Testing
- HIV-infected persons may have compromised ability to react to tuberculin tests due to cutaneous anergy 1
- Anergy testing is not recommended for routine use in persons with HIV infection or other immunocompromised states 1
- If anergy testing is performed, it should include mumps and Candida skin tests, with positivity defined as ≥5 mm induration 1
Follow-up Evaluation
For Positive Tuberculin Tests
- All persons with positive results should undergo further examination, typically starting with a chest radiograph 1
- Collection of specimens for mycobacteriologic testing (e.g., sputum) is determined case-by-case and not recommended for healthy contacts with normal chest radiographs 1
- High-priority contacts (due to special susceptibility or vulnerability) should undergo further examination regardless of skin test results 1
Window Period
- A negative test result obtained <8 weeks after exposure is considered unreliable for excluding infection 1
- Follow-up testing at 8-10 weeks after exposure ends is recommended for contacts with initial negative results 1
Common Pitfalls and Caveats
- False-negative results may occur in immunosuppressed individuals, very young children, or those with overwhelming TB disease 2
- The positive predictive value of the test varies significantly with the prevalence of TB infection in the tested population 1, 3
- Boosting phenomenon may occur with serial testing and can be misinterpreted as new infection 1
- Terminal digit preference by inexperienced readers can lead to measurement errors 4
- Environmental mycobacteria can cause cross-reactivity and false-positive results 4, 3
The tuberculin skin test remains a valuable tool for TB infection diagnosis when properly administered and interpreted according to risk-stratified guidelines 5, 3.